Brooks Automation (BRKS) Cash Flow Statement

Click line-items for a historical chart and %

Net income	-69.48M
Depreciation and amortization
Sale of intellectual property rights
Stock-based compensation	11.74M
Amortization of premium on marketable securities
Undistributed (earnings) losses of joint ventures
(Gain) loss on disposal of long-lived assets	-41K
Sale of contract manufacturing business
Loss on investment
Accounts receivable	-1.8M
Inventories	8.57M
Prepaid expenses and other current assets	-428K
Accounts payable	-5.14M
Deferred revenue	-3.29M
Accrued warranty and retrofit costs	290K
Accrued compensation and benefits	-3.23M
Accrued restructuring costs	3.86M
Accrued expenses and other
Net cash provided by operating activities
Purchases of property, plant and equipment	-12.85M
Purchases of marketable securities	-12.9M
Sale/maturity of marketable securities	139.39M
Increase in restricted cash	0
Proceeds from the sale of the contract manufacturing business
Proceeds from assets sold
Acquisition of RTS Life Sciences, net of cash acquired	-125.25M
Proceeds from the sale of intellectual property rights
Purchase of intangible assets
Other
Net cash provided by (used in) investing activities
Proceeds from issuance of common stock, net of issuance costs
Net cash provided by financing activities
Effects of exchange rate changes on cash and cash equivalents	1.65M
Net increase (decrease) in cash and cash equivalents	4.36M
Cash and cash equivalents, beginning of period	80.72M
Cash and cash equivalents, end of period	85.09M

Entities mentioned with BRKS

View All Entities